Personalized functional network connectivity abnormalities in chronic insomnia disorder

慢性失眠症患者的个性化功能网络连接异常

阅读:2

Abstract

BACKGROUND: Chronic insomnia disorder (CID) is associated with disrupted functional brain networks, yet prior research has focused primarily on group-level analyses. This study employed personalized functional network mapping to identify connectivity abnormalities in CID. METHODS: Resting-state functional magentic resonance imaging (rs-fMRI) data were collected from 86 CID patients and 38 good sleeper controls (GSCs). Using non-negative matrix factorization (NMF), we derived individualized large-scale brain networks for each participant to uncover subject-specific connectivity changes in CID. We also constructed functional network connectivity (FNC) matrices using Pearson correlation coefficients and compared global and local graph-theory metrics across groups based on these individualized networks. RESULTS: FNC analysis revealed significant differences between CID patients and GSCs within the default mode network (DMN), ventral attention network, visual network (VIS), and other key brain regions. CID exhibited altered global network topology and significant differences in local topological properties. At the global level, CID demonstrated significantly higher small-worldness (Sigma) and normalized clustering coefficient (Gamma). At the nodal level, CID showed increased local efficiency and clustering coefficient, as well as decreased nodal efficiency in the DMN, along with increased degree centrality in the VIS. CONCLUSION: By focusing on individualized functional connectivity, this approach reveals unique "fingerprint" alterations in CID. These findings provide novel insights into CID's neurobiological mechanisms and underscore the value of personalized network approaches for understanding and treating sleep disorders.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。